Angiochem Inc.
logo BDC

Angiochem Inc.

Angiochem is a clinical-stage biotechnology company discovering and developing new breakthrough drugs that are leveraging the LRP-1 mediated pathway to cross the blood-brain barrier (BBB) to treat brain diseases.

Investment year:  2005
Industry sector:  Drugs
Region:  Quebec
Follow Angiochem Inc.

Recent news

Angiochem presents at the 2012 Barriers of the CNS Gordon Research Conference

Learn More